BCEL

BCEL	BCEL	BCEL	BCEL	BCEL	BCEL	BCEL	BCEL	BCEL				BCEL	BCEL	BCEL	BCEL
35.11	35.11	35.11	35.11	35.11	35.11	35.11	35.11	35.11				35.11	35.11	35.11	35.11
$1.54	$1.54	$1.65	$1.58	$1.57	$1.77	$1.83	$1.81	$1.75				$1.54	$1.54	$1.60	$0.85
$4.17	$4.17	$4.17	$4.17	$4.17	$4.17	$4.17	$4.17	$4.17				$4.17	$4.17	$4.17	$4.17
$92.37	$92.37	$88.51	$90.97	$91.32	$84.47	$82.19	$82.89	$85.00				$92.37	$92.37	$90.26	$116.60
$54.07	$54.07	$57.93	$55.47	$55.12	$61.97	$64.25	$63.55	$61.44				$54.07	$54.07	$56.18	$29.84

 

BCEL

News, March 04, 2022
4:38 pm ET	12 Health Care Stocks Moving In Friday's After-Market Session(Benzinga)
3:59 pm ET	*Atreca Shares Spike To Over $5 Level, Now Up 200% For Session(Benzinga)
3:54 pm ET	*Atreca Shares Spike To Session High, Upside Intensifies Sharply Over Last Few Mins; Shares Up 135% For Session Near $4 Level(Benzinga)
3:52 pm ET	Atreca, Inc. CEO John Orwin on Q4 2021 Results -- Earnings Call Transcript >BCEL(Dow Jones)
1:08 pm ET	*Atreca shares are trading higher after the company reported Q4 earnings results and updated investors on its ongoing ATRC-101 Phase 1b trial.(Benzinga)
1:01 pm ET	12 Health Care Stocks Moving In Friday's Intraday Session(Benzinga)
8:30 am ET	Atreca to Participate in Cowen 42nd Annual Healthcare Conference(Globe Newswire)
6:40 am ET	Atreca stock price target cut to $14 from $17 at Stifel Nicolaus(MarketWatch)
March 03, 2022